Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Takeda discloses compounds with potent adenosine A3 receptor-antagonist activity

Dec. 28, 2000

Meiji Milk and Takeda to codevelop MT-201 for treatment of cryptomeria pollinosis

Dec. 28, 2000

Sumitomo reports quinazoline derivatives with potential for allergic disease treatment

Dec. 27, 2000

Inflazyme's novel asthma therapy enters phase II following U.K. approval

Dec. 27, 2000

Pyrazole derivatives from Yamanouchi inhibit CRACC and IL-2 production

Dec. 22, 2000

Schering-Plough to market pranlukast in Latin America

Dec. 22, 2000

Anti-IL-9 antibody collaboration terminated by Genentech

Dec. 22, 2000

PDE7 inhibitors and their use presented by Darwin Discovery

Dec. 19, 2000

R&D at Texas Biotechnology leads to identification of new integrin inhibitors

Dec. 19, 2000

Treatments for inflammatory disorders in development at Aventis inhibit cell adhesion

Dec. 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...